Styler, M J <br/><br/>
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.  [electronic resource] 

 -  Bone marrow transplantation  Jul 1996 
 - 171-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Anti-Bacterial Agents--adverse effects<br/>Bone Marrow Transplantation<br/>Busulfan--adverse effects<br/>Child<br/>Child, Preschool<br/>Ciprofloxacin--adverse effects<br/>Cyclophosphamide--adverse effects<br/>Estrogens--adverse effects<br/>Female<br/>Genetic Diseases, Inborn--therapy<br/>Graft vs Host Disease--prevention & control<br/>Hepatic Veno-Occlusive Disease--chemically induced<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Incidence<br/>Life Tables<br/>Liver Diseases--complications<br/>Liver Function Tests<br/>Male<br/>Methotrexate--adverse effects<br/>Middle Aged<br/>Multiple Organ Failure--chemically induced<br/>Multivariate Analysis<br/>Neoplasms--therapy<br/>Progestins--adverse effects<br/>Retrospective Studies<br/>Risk Factors<br/>Transplantation Conditioning--adverse effects<br/>Vancomycin--adverse effects